Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Immunol Allergy Clin North Am. 2011 May;31(2):343-65, x-xi. doi: 10.1016/j.iac.2011.02.003.

Future forms of immunotherapy and immunomodulators in allergic disease.

Author information

  • 1Department of Medicine, Division of Allergy and Immunology, Creighton University School of Medicine, 601 North 30th Street, Suite 3M100, Omaha, NE 68131, USA.

Abstract

Future forms of immunotherapy, particularly toll-like receptor agonists, have shown promising results in animal models of allergic disease although most have failed to translate into successful human clinical trials. These results have helped to elucidate the pleotropic roles of cytokines as well as the diverse phenotypes of allergic diseases, particularly asthma. The goals of these therapies are to improve patient symptoms and quality of life, to prevent and favorably alter disease course, and to maintain a good risk/benefit ratio along with a cost-effective profile.

Copyright © 2011 Elsevier Inc. All rights reserved.

PMID:
21530824
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk